Research Article
Enhanced External Counterpulsation for Management of Postacute Sequelae of SARS-CoV-2 Associated Microvascular Angina and Fatigue: An Interventional Pilot Study
Table 3
Change from baseline in walking distance and patient-reported outcome measures in patients with postacute sequelae of SARS-CoV-2 after a modified enhanced external counterpulsation treatment.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6MWT, six-minute walk test; BP, bodily pain; F, female; GH, general health; HADS, hospital anxiety and depression scale; M, man; MH, mental health; PH, physical health; RE, role disability due to emotional health; RP, role disability due to physical health; SD, standard deviation; SF, social function; VT, vitality; WD, walking distance. |